Find a company
Search the SBRI Healthcare and NHS Cancer Programme Innovation Open call portfolio.
If you would like further information on any of the companies listed in the Directory please contact the SBRI Healthcare PMO by email sbri@lgcgroup.com or tel: +44 20 8843 8125.
We would be happy to make introductions to the companies or provide any further feedback you require.
At a glance
Directory search results
Holly Health Ltd
| Project | Co-design of a personalised, scalable, wellbeing tool, targeting binge eating challenges in women |
|---|---|
| Description |
Holly Health is an intelligent, compassionate, fully digital, health coaching service, already used by NHS organisations in over 20 regions in the UK. The product aims to address the lack of tailored coaching support and proactive prevention services available to patients for making sustainable physical and mental health changes. |
| Funding | £ 79,247 |
| Competition | Competition 25 - Women's health |
| Competition Date | July 2024 |
| Categories | Women's health |
| Website | https://www.hollyhealth.io/ |
Unravel Health Limited
| Project | Developing a revolutionary hormone monitor to manage migraines and beyond |
|---|---|
| Description |
Unravel Health's Mini-Lab is a simple, at-home device that uses saliva to track hormone levels, instantly and simply. It helps women and clinicians understand and manage hormone-related conditions through trend data over time. |
| Funding | £ 99,725 |
| Competition | Competition 25 - Women's health |
| Competition Date | July 2024 |
| Categories | Women's health |
| Website | https://www.unravel.health/ |
Liberum Health Ltd
| Project | Novel, Non-Invasive Alternative to Oral Therapies for Pelvic Pain caused by menstrual pain and/or Endometriosis |
|---|---|
| Description |
Tampon-like devices (TLDs) for drug delivery are innovative tools designed to administer therapeutic agents directly to targeted areas within the female pelvic region. These devices use the familiar form and function of traditional tampons to deliver drugs in a controlled manner via the intravaginal route. Our TLD utilises BioHastalex®. This material is biocompatible, non-toxic, recyclable, and biodegradable in seawater and landfills within a year, addressing both health and environmental concerns. Patent protection has been filed, highlighting the uniqueness and commercial potential of our solution. Dysmenorrhea affects over 80% of all women at some point and often lacks clear treatment strategies. |
| Funding | £ 99,942 |
| Competition | Competition 25 - Women's health |
| Competition Date | July 2024 |
| Categories | Women's health |
| Website | https://www.liberumhealth.com/ |